Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-17
2007-07-17
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S183000
Reexamination Certificate
active
10415638
ABSTRACT:
The invention concerns a pharmaceutical composition comprising, as active principle, at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), and optionally an acceptable pharmaceutical carrier. The invention also concerns a product comprising at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), selectively or not, as combination product, the active principle being separate.
REFERENCES:
patent: 5760048 (1998-06-01), Wang et al.
patent: 2000191616 (2000-11-01), None
patent: 0132654 (2001-05-01), None
AM Mortensen and RF Novak. Toxicol. Appl. Pharmacol. (1992) 117, 180-188.
“Inhibitor” Merriam-Webster Online Dictionary. Accessed Dec. 6, 2004 http://www.m-w.com/cgi-bin/dictionary.
Definition of Cancer. Internet document <<http://www.medterms.com>> 1 page, accessed Sep. 16, 2005, last reviewed Sep. 18, 2004.
Cachexia. Internet document <<http://www.phytomedical.com/cachexia/cachexia.asp>> 3 pages, accessed Jul. 24, 2006.
Hearing Loss and Deafness: Merck Manual Home Edition. Internet document <<http://www.merck.com/mmhe/print/sec19/ch218/ch218a.html>>, 7 pages, accessed Jul. 24, 2006, reviewed Feb. 1, 2003.
Kim et al, “Regulation . . . Fibroblasts”, Cellular Signalling, (2002) 14/3 (205-210).
Banik et al, “Role . . . Inhibitors”, Annals New York Academy of Sciences, (1998), 844 (Neurochemistry of Drugs of Abuse), 131-137, XP008000950.
Blumenthanl et al, “Changes . . . Hydroxytoluene”, Archives of Biochemistry and Biophysics, New York, vol. 256, No. 1, Jul. 1987 pp. 19-28.
Wang et al, “An . . . NEUROPROTECTIVE”, Proceedings of the National Academy of Science, Washington, US, vol. 93, No. 13, Jun. 25, 1996, pp. 6687-6692.
Perrin et al, “Mise . . . Recovery”, Archives Des Maladies Du Coeur et des Vaisseaux, J.B. Balliere, Paris, France, vol. 93, No. 8, Aug. 2000, pp. 931-936.
Guttmann et al, “Oxidative . . . in Situ”, Journal of Biological Chemistry, American Society of Biological Chemists, Baltimore, MD, US, vol. 273, No. 21, May 22, 1998, pp. 13331-13338.
Auvin Serge
Chabrier de Lassauniere Pierre-Etienne
Pignol Bernadette
Kosar Andrew D.
Muserlian Charles A.
Societe de Conseils de Recherches et d' 'Applications Scientifiq
Tsang Cecilia
LandOfFree
Association of calpain inhibitors and reactive oxygen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Association of calpain inhibitors and reactive oxygen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Association of calpain inhibitors and reactive oxygen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3765760